Skip to main content

Table 2 Patient characteristics (n = 122)

From: Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience

Patient parameter Value
Median age (years; range) 71.5 (50.9–83.3)
Gleason score, n (%)
Low risk (2–6) 50 (41%)
Intermediate risk (7) 48 (39.3%)
High risk (8–10) 23 (18.9%)
Serum PSA (ng/ml), n (%)
Low risk (<10) 52 (42.6%)
Intermediate risk (10–20) 38 (31.1%)
High risk (>20) 32 (26.2%)
Initial tumor stage (clinical examination and CT), n (%)
Low risk (T1–2a) 53 (43.4%)
Intermediate risk (T2b-c) 44 (36.1%)
High risk: extracapsular extension (T3a) 21 (17.2%)
High risk: seminal vesicle infiltration (T3b) 4 (3.3%)
\